339 related articles for article (PubMed ID: 21092522)
1. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
Alcock GS; Liley H
Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
5. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
[TBL] [Abstract][Full Text] [Related]
6. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
Okwundu CI; Okoromah CA; Shah PS
Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
[TBL] [Abstract][Full Text] [Related]
8. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
Keir AK; Dunn M; Callum J
J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
[TBL] [Abstract][Full Text] [Related]
9. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
Osborn LM; Lenarsky C; Oakes RC; Reiff MI
Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
[TBL] [Abstract][Full Text] [Related]
10. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.
Al-Lawama M; Badran E; Elrimawi A; Bani Mustafa A; Alkhatib H
J Clin Med Res; 2019 Nov; 11(11):760-763. PubMed ID: 31803318
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
Mundy CA
Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
[TBL] [Abstract][Full Text] [Related]
14. [High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization].
Monpoux F; Dageville C; Maillotte AM; De Smet S; Casagrande F; Boutté P
Arch Pediatr; 2009 Sep; 16(9):1289-94. PubMed ID: 19586760
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
17. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
Gottstein R; Cooke RW
Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
Louis D; More K; Oberoi S; Shah PS
Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
[TBL] [Abstract][Full Text] [Related]
20. Double phototherapy in jaundiced term infants with hemolysis.
Thaithumyanon P; Visutiratmanee C
J Med Assoc Thai; 2002 Nov; 85(11):1176-81. PubMed ID: 12546314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
